150 related articles for article (PubMed ID: 10411175)
1. Treatment of psoriasis with calcipotriene plus psoralen-UV-A-bath therapy.
Grundmann-Kollmann M; Behrens S; Krähn G; Leiter U; Ochsendorf F; Kaufmann R; Peter RU; Kerscher M
Arch Dermatol; 1999 Jul; 135(7):861-2. PubMed ID: 10411175
[No Abstract] [Full Text] [Related]
2. Vitamin D and psoralen plus UVA radiation.
Mascaró JM
Cutis; 2002 Nov; 70(5 Suppl):13-5. PubMed ID: 12467334
[TBL] [Abstract][Full Text] [Related]
3. Reduction of UV-A radiation induced by calcipotriol in the treatment of vulgar psoriasis with oral psoralen plus UV-A.
Kokelj F; Plozzer C; Torsello P
Arch Dermatol; 1997 May; 133(5):668-9. PubMed ID: 9158432
[No Abstract] [Full Text] [Related]
4. An unusual bullous eruption in a patient with psoriasis: Calcipotriene phototoxicity.
Anolik R; Brauer JA; Soter NA
J Am Acad Dermatol; 2010 Jun; 62(6):1081-2. PubMed ID: 20466193
[No Abstract] [Full Text] [Related]
5. Phototherapy of psoriasis: comparative experience of different phototherapeutic approaches.
Karrer S; Eholzer C; Ackermann G; Landthaler M; Szeimies RM
Dermatology; 2001; 202(2):108-15. PubMed ID: 11306830
[TBL] [Abstract][Full Text] [Related]
6. UVB blocking effect of calcipotriene ointment 0.005%.
Marsico RE; Dijkstra JW
J Am Acad Dermatol; 1996 Mar; 34(3):539-40. PubMed ID: 8609280
[No Abstract] [Full Text] [Related]
7. Calcipotriol/calcipotriene (Dovonex/Daivonex) in combination with phototherapy: a review.
Koo J
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S59-61. PubMed ID: 9344187
[TBL] [Abstract][Full Text] [Related]
8. Interactions between calcipotriene and ultraviolet light.
Lebwohl M; Hecker D; Martinez J; Sapadin A; Patel B
J Am Acad Dermatol; 1997 Jul; 37(1):93-5. PubMed ID: 9216529
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the potential clinical benefits of switching patients with plaque psoriasis from calcipotriene to tazarotene treatment.
Coynik D
Cutis; 2000 Dec; 66(6 Suppl):19-24. PubMed ID: 11147087
[TBL] [Abstract][Full Text] [Related]
10. Treatment of psoriasis: role of calcipotriene.
Kirsner RS; Federman D
Am Fam Physician; 1995 Jul; 52(1):237-40, 243-4. PubMed ID: 7604767
[TBL] [Abstract][Full Text] [Related]
11. Calcipotriene for psoriasis.
Med Lett Drugs Ther; 1994 Aug; 36(928):70-1. PubMed ID: 8035754
[No Abstract] [Full Text] [Related]
12. Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial.
Menter A; Gold LS; Bukhalo M; Grekin S; Kempers S; Boyce BM; Ganslandt C; Villumsen J; Lebwohl M
J Drugs Dermatol; 2013 Jan; 12(1):92-8. PubMed ID: 23377334
[TBL] [Abstract][Full Text] [Related]
13. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
[TBL] [Abstract][Full Text] [Related]
14. Generalized pustular psoriasis in a child: observation of long-term combination therapy with etretinate and calcipotriol for 16 years.
Umezawa Y; Mabuch T; Ozawa A
Pediatr Dermatol; 2012; 29(2):206-8. PubMed ID: 22409471
[TBL] [Abstract][Full Text] [Related]
15. Combination regimens of topical calcipotriene in chronic plaque psoriasis: systematic review of efficacy and tolerability.
Ashcroft DM; Li Wan Po A; Williams HC; Griffiths CE
Arch Dermatol; 2000 Dec; 136(12):1536-43. PubMed ID: 11115167
[TBL] [Abstract][Full Text] [Related]
16. Trends in on and off-label calcipotriene use.
Pearce DJ; Camacho F; Balkrishnan R; Fleischer AB; Feldman SR
J Dermatolog Treat; 2006; 17(5):308-13. PubMed ID: 17092863
[TBL] [Abstract][Full Text] [Related]
17. Comparison of calcipotriene (Dovonex) with a coal tar emulsion (Exorex) in treating psoriasis in adults: a pilot study.
Veronikis IE; Malabanan AO; Holick MF
Arch Dermatol; 1999 Apr; 135(4):474-5. PubMed ID: 10206065
[No Abstract] [Full Text] [Related]
18. Calcipotriene ointment applied once a day for psoriasis: a double-blind, multicenter, placebo-controlled study.
Pariser DM; Pariser RJ; Breneman D; Lebwohl M; Kalb R; Moore J; Moss H; Parker C; Fiedler V
Arch Dermatol; 1996 Dec; 132(12):1527. PubMed ID: 8961897
[No Abstract] [Full Text] [Related]
19. Preliminary study of the efficacy and tolerability of combination therapy with calcipotriene ointment 0.005% and tacrolimus ointment 0.1% in the treatment of stable plaque psoriasis.
Tirado-Sánchez A; Ponce-Olivera RM
Cutis; 2012 Sep; 90(3):140-4. PubMed ID: 23094314
[TBL] [Abstract][Full Text] [Related]
20. Long-term effectiveness and safety of topical calcipotriene for psoriasis. Calcipotriene Study Group.
Cullen SI
South Med J; 1996 Nov; 89(11):1053-6. PubMed ID: 8903286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
